The Collaborative Research Center 1192 (SFB 1192) "Immune-Mediated Glomerular Diseases" of the University Medical Center Hamburg-Eppendorf (UKE) will be funded for another four years. The DFG has approved 12 million euros for this. The SFB 1192 (established in 2015) investigates inflammatory kidney diseases and aims to develop new treatment concepts for autoimmune kidney diseases. UKE scientists are working together with colleagues from the Universities of Hamburg and Bonn.
Press Release:
UKE - Pressemitteilung - Großer Erfolg für Nierenforscher im UKE: Sonderforschungsbereich wird fortgesetzt